d-alpha tocopherol has been researched along with Head and Neck Neoplasms in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (18.92) | 18.2507 |
| 2000's | 19 (51.35) | 29.6817 |
| 2010's | 8 (21.62) | 24.3611 |
| 2020's | 3 (8.11) | 2.80 |
| Authors | Studies |
|---|---|
| Djuric, Z; Duffy, SA; Fowler, KE; Ren, J; Ronis, DL | 1 |
| Bairati, I; Brochet, F; Fortin, A; Gélinas, M; Meyer, F; Nabid, A; Nourissat, A; Têtu, B | 1 |
| Holečková, P; Kalábová, H; Kašparová, M; Krčmová, L; Melichar, B; Pála, M; Plíšek, J; Solichová, D; Studentová, H; Vítek, P; Zezulová, M | 1 |
| Barletta, A; Barletta, D; Braga-Filho, A; Diehl, A; Ferreira, PR; Fleck, JF; Ilha, L | 1 |
| Hong, WK; Kim, ES | 1 |
| Bairati, I; Brochet, F; del Vecchio, P; Fortin, A; Gélinas, M; Harel, F; Mâsse, B; Mercier, JP; Meyer, F; Nabid, A; Roy, J; Têtu, B; Vass, S; Vigneault, E | 1 |
| Camphausen, K; Citrin, D; Krishna, MC; Mitchell, JB | 1 |
| Abdous, B; Bairati, I; Brochet, F; Del Vecchio, P; Fortin, A; Gélinas, M; Harel, F; Mercier, JP; Meyer, F; Nabid, A; Roy, J; Têtu, B; Vass, S; Vigneault, E | 1 |
| Cole, WC; Prasad, KN | 1 |
| Bairati, I; Brochet, F; Fortin, A; Gélinas, M; Jobin, E; Meyer, F; Nabid, A; Têtu, B | 1 |
| Beevi, SS; Geetha, A; Rasheed, MH | 1 |
| Albanes, D; Edwards, BK; Hartman, AM; Huttunen, JK; Pietinen, P; Taylor, PR; Virtamo, J; Wright, ME | 1 |
| Bairati, I; Fortin, A; Gélinas, M; Jobin, E; Meyer, F; Nabid, A; Têtu, B | 1 |
| Bairati, I; Brochet, F; Fortin, A; Gélinas, M; Jobin, E; Lussier, S; Meyer, F; Nabid, A; Sackett, MK; Têtu, B | 1 |
| Beheshti, S; Cheng, H; Kwok, J; Patel, V; Samani, M; Sproat, C | 1 |
| Cape, A; Kwok, J; Mahendran, K; Mellor, A; Patel, V; Sproat, C; Young, H | 1 |
| Ahmed, SF; Bakr, MA; Rasmy, AH | 1 |
| El Wakeel, L; El-Hamamsy, M; Kelany, M; Saad, AS; Sayed, R | 1 |
| Brennan, PA; Kumar, R; Lyons, A; Osher, J; Warner, E | 1 |
| A Lee, YC; Boffetta, P; Bosetti, C; Chuang, SC; Decarli, A; Edefonti, V; Ferraroni, M; Hashibe, M; Kelsey, K; La Vecchia, C; Levi, F; Matsuo, K; McClean, M; Morgenstern, H; Moysich, K; Olshan, AF; Parpinel, M; Schantz, S; Serraino, D; Turati, F; Winn, DM; Yu, GP; Zevallos, JP; Zhang, ZF | 1 |
| de Munter, L; Kremer, B; Maasland, DH; Schouten, LJ; van den Brandt, PA | 1 |
| Ahn, YC; Choi, JY; Chung, MK; Kim, do H; Kim, EH; Son, YI | 1 |
| Bairati, I; Fortin, A; Liu, G; Meyer, F; Wang, CS | 1 |
| Kuebler, AC; Scheer, M; Zöller, JE | 1 |
| Argyriou, AA; Chroni, E; Ellul, J; Iconomou, G; Kalofonos, HP; Katsoulas, G; Koutras, A; Papapetropoulos, S | 1 |
| Francisco, M; Hong, WK; Khuri, FR; Kim, E; Murphy, B; Richards, T; Seixas-Silva, JA; Shin, DM; Wieand, HS | 1 |
| Argyriou, AA; Chroni, E; Iconomou, G; Kalofonos, HP; Koutras, A; Papapetropoulos, S; Polychronopoulos, P | 1 |
| Cai, H; Califano, JA; Dong, Y; Gu, X; Guo, Y; Pang, X; Song, X; Sridhar, R; Walters, E; Xie, T; Zhang, R | 1 |
| Goepfert, H; Hong, WK; Hsu, TC; Lee, JJ; Schantz, SP; Spitz, MR; Trizna, Z | 1 |
| Bairati, I; Brochet, F; Gélinas, M; Mâsse, B; Meyer, F; Nabid, A; Roy, J; Têtu, B | 2 |
| Clayman, G; El-Naggar, AK; Fan, Y; Hittelman, WN; Hong, WK; Lee, JJ; Lee, JS; Lippman, SM; Mao, L; Papadimitrakopoulou, V; Shin, DM; Shin, HC; Zhou, X | 1 |
| Quirk, WS; Seidman, MD; Shirwany, NA | 1 |
| Balla-Mekias, S; Delanian, S; Lefaix, JL | 1 |
| Clayman, G; El-Naggar, A; Gillenwater, A; Hittelman, WN; Hong, WK; Lee, JJ; Lee, JS; Lippman, SM; Mao, L; Myers, J; Papadimitrakopoulou, VM; Shin, DM; Shin, HJ | 1 |
| Ang, KK; Clayman, G; Francisco, M; Garden, AS; Gillenwater, A; Ginsberg, L; Glisson, BS; Goepfert, H; Hong, WK; Khuri, FR; Lippman, SM; Liu, D; Morrison, W; Murphy, B; Myers, J; Papadimitrakopoulou, V; Shin, DM | 1 |
| de Vries, N; Snow, GB | 1 |
5 review(s) available for d-alpha tocopherol and Head and Neck Neoplasms
| Article | Year |
|---|---|
An apple a day...does it really keep the doctor away? The current state of cancer chemoprevention.
Topics: alpha-Tocopherol; Anticarcinogenic Agents; Antioxidants; beta Carotene; Biomarkers, Tumor; Double-Blind Method; Head and Neck Neoplasms; Humans; Multicenter Studies as Topic; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Radiotherapy; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Failure; Treatment Outcome | 2005 |
Chemoprevention of oral squamous cell carcinomas.
Topics: Antineoplastic Agents; Ascorbic Acid; Carcinoma, Squamous Cell; Carotenoids; Chemoprevention; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Neoplasms, Second Primary; Retinoids; Treatment Outcome; Vitamin E | 2004 |
[Prevention of second primary cancer with vitamin supplementation in patients treated for head and neck cancers].
Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; beta Carotene; Carcinoma, Squamous Cell; Carotenoids; Follow-Up Studies; Head and Neck Neoplasms; Humans; Neoplasm Staging; Neoplasms, Second Primary; Risk Factors; Vegetables; Vitamin A; Vitamin E; Vitamins | 1996 |
[Incidence and risk factors of second primary cancers in patients treated for primary pharyngeal cancer].
Topics: Canada; Head and Neck Neoplasms; Humans; Incidence; Lung Neoplasms; Neoplasms, Second Primary; Pharyngeal Neoplasms; Registries; Risk Factors; Vitamin A; Vitamin E | 1996 |
Reactive oxygen metabolites, antioxidants and head and neck cancer.
Topics: Animals; Antioxidants; Apoptosis; beta Carotene; Chemoprevention; Diet; Head and Neck Neoplasms; Humans; Reactive Oxygen Species; Vitamin E | 1999 |
16 trial(s) available for d-alpha tocopherol and Head and Neck Neoplasms
| Article | Year |
|---|---|
Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer.
Topics: alpha-Tocopherol; beta Carotene; Body Weight; Carcinoma, Squamous Cell; Causality; Chemoprevention; Chemoradiotherapy; Comorbidity; Double-Blind Method; Eating; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mucositis; Neoplasm Staging; Neoplasms, Second Primary; Population Surveillance; Quality of Life; Radiotherapy; Risk Factors; Surveys and Questionnaires; Weight Loss | 2012 |
Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: a double-blind randomized trial.
Topics: alpha-Tocopherol; Carcinoma, Squamous Cell; Double-Blind Method; Eating; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mouth Mucosa; Mouthwashes; Pain; Radiation Injuries; Radiation-Protective Agents; Surveys and Questionnaires; Treatment Outcome; Weight Loss | 2004 |
A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.
Topics: Adult; Aged; alpha-Tocopherol; Anticarcinogenic Agents; Antioxidants; beta Carotene; Confounding Factors, Epidemiologic; Double-Blind Method; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Incidence; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Odds Ratio; Proportional Hazards Models; Radiotherapy; Survival Analysis; Treatment Failure | 2005 |
Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients.
Topics: Acute Disease; alpha-Tocopherol; Analysis of Variance; Antioxidants; beta Carotene; Chi-Square Distribution; Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Proportional Hazards Models; Quality of Life; Radiation Injuries; Survival Analysis | 2005 |
Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients.
Topics: alpha-Tocopherol; Antioxidants; beta Carotene; Dietary Supplements; Head and Neck Neoplasms; Humans; Placebos; Survival Analysis; Vitamins | 2006 |
Effects of alpha-tocopherol and beta-carotene supplementation on upper aerodigestive tract cancers in a large, randomized controlled trial.
Topics: Aged; alpha-Tocopherol; beta Carotene; Dietary Supplements; Double-Blind Method; Head and Neck Neoplasms; Humans; Incidence; Male; Middle Aged; Primary Prevention; Smoking; Vitamins | 2007 |
Acute adverse effects of radiation therapy and local recurrence in relation to dietary and plasma beta carotene and alpha tocopherol in head and neck cancer patients.
Topics: alpha-Tocopherol; Antioxidants; beta Carotene; Confidence Intervals; Diet; Dietary Supplements; Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Prospective Studies; Radiation Injuries; Surveys and Questionnaires | 2007 |
Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer.
Topics: Aged; alpha-Tocopherol; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cyclooxygenase 2; Double-Blind Method; Female; Glottis; Head and Neck Neoplasms; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Laryngeal Neoplasms; Male; Middle Aged; Neoplasms, Second Primary; Placebos; Prognosis; Vitamins | 2008 |
Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study.
Topics: Aged; Antioxidants; Deglutition Disorders; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Pentoxifylline; Phosphodiesterase Inhibitors; Radiotherapy; Stomatitis; Vitamin E | 2019 |
Randomized Trial of Vitamin C/E Complex for Prevention of Radiation-Induced Xerostomia in Patients with Head and Neck Cancer.
Topics: Ascorbic Acid; Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Prospective Studies; Radiation Injuries; Surveys and Questionnaires; Treatment Outcome; Vitamin E; Xerostomia | 2016 |
Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy.
Topics: Acute Disease; beta Carotene; Body Mass Index; Confidence Intervals; Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Karnofsky Performance Status; Logistic Models; Male; Middle Aged; Neoplasm Staging; Odds Ratio; Prospective Studies; Quebec; Radiation Injuries; Sex Factors; Vitamin E; Vitamins; Weight Loss | 2012 |
Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial.
Topics: Administration, Oral; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peripheral Nervous System Diseases; Pilot Projects; Testicular Neoplasms; Uterine Cervical Neoplasms; Vitamin E | 2005 |
Phase 2 bioadjuvant study of interferon alfa-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-up.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Drug Therapy, Combination; Head and Neck Neoplasms; Humans; Interferon alpha-2; Interferon-alpha; Isotretinoin; Neoplasms, Second Primary; Prospective Studies; Recombinant Proteins; Vitamin E | 2005 |
A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results.
Topics: Action Potentials; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Carcinoma, Small Cell; Cisplatin; Dietary Supplements; Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Peripheral Nervous System Diseases; Peroneal Nerve; Psychomotor Performance; Research Design; Severity of Illness Index; Stomach Neoplasms; Testicular Neoplasms; Treatment Outcome; Ulnar Nerve; Uterine Cervical Neoplasms; Vitamin E | 2006 |
Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression.
Topics: Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Immunohistochemistry; Interferon-alpha; Isotretinoin; Mutation; Precancerous Conditions; Prospective Studies; Treatment Outcome; Tumor Suppressor Protein p53; Vitamin E | 2000 |
Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Drug Synergism; Female; Head and Neck Neoplasms; Humans; Interferon-alpha; Isotretinoin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Survival Analysis; Survival Rate; Vitamin E | 2001 |
16 other study(ies) available for d-alpha tocopherol and Head and Neck Neoplasms
| Article | Year |
|---|---|
Levels of fat-soluble micronutrients and 2,6-cyclolycopene-1,5-diol in head and neck cancer patients.
Topics: Adult; Aged; alpha-Tocopherol; beta Carotene; Carotenoids; Case-Control Studies; Cohort Studies; Cryptoxanthins; Diet Records; Female; gamma-Tocopherol; Head and Neck Neoplasms; Humans; Lutein; Lycopene; Male; Micronutrients; Middle Aged; Neoplasms, Squamous Cell; Oxidative Stress; Pilot Projects; Prospective Studies; Smoking; Xanthophylls; Zeaxanthins | 2007 |
Prognostic significance of serum retinol, serum alpha-tocopherol, and urinary neopterin in patients with head and neck carcinoma treated with external beam radiation.
Topics: Adult; Aged; alpha-Tocopherol; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neopterin; Prognosis; Vitamin A | 2012 |
Implications for tumor control during protection of normal tissues with antioxidants.
Topics: alpha-Tocopherol; Antioxidants; beta Carotene; Head and Neck Neoplasms; Humans; Lung Neoplasms; Randomized Controlled Trials as Topic; Smoking; Vitamin A | 2005 |
Antioxidants in cancer therapy.
Topics: Acute Disease; alpha-Tocopherol; Antioxidants; Drug Administration Schedule; Head and Neck Neoplasms; Humans; Incidence; Neoplasm Recurrence, Local; Radiation Injuries; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Tocopherols; Vitamin E; Vitamins | 2006 |
Enhanced lipid peroxidation and nitric oxide products with deranged antioxidant status in patients with head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; alpha-Tocopherol; Antioxidants; Ascorbic Acid; Carcinoma, Squamous Cell; Catalase; Female; Glutathione; Glutathione Peroxidase; Head and Neck Neoplasms; Humans; Lipid Peroxidation; Lipid Peroxides; Male; Malondialdehyde; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Reactive Nitrogen Species; Reactive Oxygen Species; Smoking; Superoxides | 2007 |
Prophylactic pentoxifylline and vitamin E use for dental extractions in irradiated patients with head and neck cancer.
Topics: Head and Neck Neoplasms; Humans; Osteoradionecrosis; Pentoxifylline; Retrospective Studies; Tooth Extraction; Vitamin E | 2022 |
The use of liquid formulation pentoxifylline and vitamin E in both established and as a prophylaxis for dental extractions "at risk" of osteoradionecrosis.
Topics: Head and Neck Neoplasms; Humans; Osteoradionecrosis; Pentoxifylline; Retrospective Studies; Tooth Extraction; Vitamin E | 2023 |
Vitamin E ameliorates oral mucositis in gamma-irradiated rats (an in vivo study).
Topics: Animals; Head and Neck Neoplasms; Humans; Male; Mucositis; Radiation Injuries; Rats; Stomatitis; Tongue; Vitamin E | 2023 |
Osteoradionecrosis--a review of current concepts in defining the extent of the disease and a new classification proposal.
Topics: Antioxidants; Free Radical Scavengers; Head and Neck Neoplasms; Humans; Hyperbaric Oxygenation; Osteoradionecrosis; Pentoxifylline; Surgical Flaps; Vitamin E | 2014 |
Vitamin E intake from natural sources and head and neck cancer risk: a pooled analysis in the International Head and Neck Cancer Epidemiology consortium.
Topics: Adult; Aged; Female; Head and Neck Neoplasms; Humans; Male; Vitamin E | 2015 |
Vitamin and carotenoid intake and risk of head-neck cancer subtypes in the Netherlands Cohort Study.
Topics: Aged; Antioxidants; Ascorbic Acid; Carotenoids; Case-Control Studies; Cohort Studies; Diet; Dietary Supplements; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Incidence; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Netherlands; Oropharyngeal Neoplasms; Prospective Studies; Registries; Risk Factors; Vitamin E | 2015 |
Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Caspase 9; Cell Proliferation; Cell Survival; Ceramides; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Tocopherols; Tumor Cells, Cultured; Vitamin E; Xenograft Model Antitumor Assays | 2008 |
In vitro protective effects of chemopreventive agents against bleomycin-induced genotoxicity in lymphoblastoid cell lines and peripheral blood lymphocytes of head and neck cancer patients.
Topics: Acetylcysteine; Anticarcinogenic Agents; Antimutagenic Agents; Ascorbic Acid; Bleomycin; Cell Line; Chromosome Aberrations; Head and Neck Neoplasms; Humans; Lymphocytes; Tretinoin; Vitamin E | 1993 |
Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy.
Topics: Antineoplastic Agents; Chromosomes, Human, Pair 9; DNA, Neoplasm; Female; Genotype; Head and Neck Neoplasms; Humans; Interferon-alpha; Isotretinoin; Loss of Heterozygosity; Male; Microsatellite Repeats; Phenotype; Polymerase Chain Reaction; Precancerous Conditions; Prospective Studies; Vitamin E | 1998 |
Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol.
Topics: Adult; Aged; Breast Neoplasms; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Pentoxifylline; Pulmonary Fibrosis; Radiation Injuries; Radiation-Protective Agents; Radiotherapy; Treatment Outcome; Vitamin E | 1999 |
Relationships of vitamins A and E and beta-carotene serum levels to head and neck cancer patients with and without second primary tumors.
Topics: beta Carotene; Carcinoma, Squamous Cell; Carotenoids; Head and Neck Neoplasms; Humans; Neoplasms, Multiple Primary; Vitamin A; Vitamin E | 1990 |